
News
Advertisement


Advertisement




Advertisement








Osteomyelitis a debilitating bone infection most frequently caused by Staphylococcus aureus bacteria is particularly challenging to treat. Now, Vanderbilt microbiologist Eric Skaar, PhD, MPH, and colleagues have identified a staph-killing compound that may be an effective treatment for osteomyelitis, and they have developed a new mouse model that will be useful for testing this compound and for generating additional therapeutic strategies.















Integrated Medical Systems International, Inc. (IMS) has moved one of its two major repair facilities into a newly renovated, 55,000-square-foot operations center.
Advertisement
Advertisement

